These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30836181)

  • 1. SOFTs - Structured orodispersible film templates.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
    Speer I; Preis M; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
    Speer I; Lenhart V; Preis M; Breitkreutz J
    Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
    Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
    Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
    Woertz C; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on disintegration methods for oral film preparations.
    Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
    Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instant ODFs - Development of an intermediate, nanoparticle-based product platform for individualized medication.
    Steiner D; Finke JH; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():149-158. PubMed ID: 28414191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
    Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
    Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
    Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based Orodispersible Films Loaded with Entecavir: Formulation and
    Wei T; Zhou BY; Wu XH; Liu XA; Huo MW; Huang XX; Shi LZ; Shi LL; Cao QR
    Curr Drug Deliv; 2024; 21(10):1362-1374. PubMed ID: 37929732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edible solid foams as porous substrates for inkjet-printable pharmaceuticals.
    Iftimi LD; Edinger M; Bar-Shalom D; Rantanen J; Genina N
    Eur J Pharm Biopharm; 2019 Mar; 136():38-47. PubMed ID: 30630061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
    Song Q; Guo X; Sun Y; Yang M
    AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PVA-based formulations as a design-technology platform for orally disintegrating film matrices.
    Kozakiewicz-Latała M; Dyba AJ; Marciniak D; Szymczyk-Ziółkowska P; Cieszko M; Nartowski KP; Nowak M; Karolewicz B
    Int J Pharm; 2024 Nov; 665():124666. PubMed ID: 39265848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
    Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
    Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and In Vitro Evaluation of Montelukast Sodium-Loaded 3D Printed Orodispersible Films for the Treatment of Asthma.
    Özcan-Bülbül E; Kalender Y; Bal-Öztürk A; Üstündağ-Okur N
    AAPS PharmSciTech; 2024 Sep; 25(7):218. PubMed ID: 39289238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.